In addition, genetic risk factor APOEε4, known to increase the presence of AD co-pathology [54], was found to be associated with a greater expression of microglial markers CD68 and HLA-DR and reduced expression of Iba1 [55]. Here, CD68 is linked to Alzheimer disease.